Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/4/11 → 10/4/14 |
Funding
- Therapeutics, Inc. (SHP-141-001 // SHP-141-001)
- Shape Pharmaceuticals, Inc. (SHP-141-001 // SHP-141-001)
Prot# SHP-141-001: A Randomized, Double-blind, Placebo-Controlled, Dose-Escalating, Phase 1B Study to Assess the Safety, Pharmacodynamics and Pharmacokinetics of SHP-141, A Histone Deacetylase Inhibitor, Administered Topically up to 28 Days to Patients wi
- Guitart, Joan (PD/PI)
- Pedram, Gerami (Co-PD/PI)
- West, Dennis P (Co-PD/PI)
Project: Research project